QTRXQuanterix Corp
Laboratory Analytical Instruments
- Revenue
- $139M
- 1.1% YoY
- Operating margin
- -90.4%
- 136% YoY
- EBITDA
- −$119M
- 148% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$42M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired15% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $111M | $106M | $122M | $137M | $139M | 1.1% |
| Operating income | −$57M | −$104M | −$46M | −$53M | −$126M | 139% |
| Net income | −$56M | −$100M | −$28M | −$39M | −$107M | 178% |
| Operating cash flow | −$48M | −$49M | −$19M | −$35M | −$77M | 120% |
| Capex | $14M | $12M | $4M | $3M | $3M | 22% |
| Stock-based comp | $16M | $15M | $17M | $20M | $21M | 3.7% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 14 | 125 |
| FY2024 | — | — | 23 | 93 |
| FY2023 | — | — | 59 | 94 |
| FY2022 | — | — | 30 | 90 |
| FY2021 | — | — | 91 | 100 |